Latest News in the pharma Industry

Biopharma News

Pfizer to sell Chinese biologics manufacturing facility to WuXi

Pfizer to sell Chinese biologics manufacturing facility to WuXi

17 Mar 2021

Multinational makes ‘difficult decision’ to halt presence in Chinese biosimilars market five years after $350 million investment

Read more 
Wuxi Vaccines' Ireland site still on course for 2022 despite COVID challenges

Wuxi Vaccines' Ireland site still on course for 2022 despite COVID challenges

16 Mar 2021

Despite COVID-related challenges and supply chain issues, the CDMO's $240 million new facility is on target to open next year

Read more 
Special Podcast: CPhI Outlook Roundtable - Listen Now

Special Podcast: CPhI Outlook Roundtable - Listen Now

9 Mar 2021

In this special roundtable podcast exploring potential opportunities in a post-vaccinated world, we are joined by a panel of three world class experts – Bikash Chatterjee, CEO of Pharmatech Associates; Parrish Galliher, Managing Director, Bi...

Read more 
Clinical Development Success Rates and Contributing Factors 2011-2020: New Report from Informa Pharma Intelligence

Clinical Development Success Rates and Contributing Factors 2011-2020: New Report from Informa Pharma Intelligence

9 Mar 2021

Biologic products advance through clinical development with a higher success rate than traditional small molecules, this new analysis of clinical development success from Informa Pharma Intelligence, the Biotechnology Industry Organization and the...

Read more 
Merck agrees to support Johnson & Johnson in vaccine manufacturing deal

Merck agrees to support Johnson & Johnson in vaccine manufacturing deal

3 Mar 2021

Funding from BARDA helps the company to adapt and make available a number of existing manufacturing facilities for the production of SARS-CoV-2 vaccines and medicines

Read more 
WuXi AppTec completes $135 million acquisition of Oxgene

WuXi AppTec completes $135 million acquisition of Oxgene

2 Mar 2021

The addition further strengthens WuXi's cell and gene therapy service offerings for global customers and will be Wuxi ATU's first facility in Europe

Read more 
Pharmaron pays $118.7 million for AbbVie UK biomanufacturing site

Pharmaron pays $118.7 million for AbbVie UK biomanufacturing site

1 Mar 2021

This transaction complements Pharmaron’s recent acquisition of Absorption Systems in the US for building an integrated cell and gene therapy services platform

Read more 
Catalent takes double action to boost cell and gene therapy services

Catalent takes double action to boost cell and gene therapy services

23 Feb 2021

The company acquires a pDNA CDMO and launches pDNA development and manufacturing services at its Rockville, Maryland facility

Read more 
BMS expands global footprint with new cell therapy manufacturing facility

BMS expands global footprint with new cell therapy manufacturing facility

23 Feb 2021

The new site will be equipped to enable quick ramp-up of capacity for clinical and commercial cell therapy products

Read more 
Catalent secures softgels commercial supply agreement with Aurinia

Catalent secures softgels commercial supply agreement with Aurinia

22 Feb 2021

The CDMO will manufacture recently FDA-approved Lupkynis as a softgel dosage form at its St Petersburg, Florida, facility

Read more 
MaxiVAX and Minaris strike immunotherapy manufacturing partnership deal

MaxiVAX and Minaris strike immunotherapy manufacturing partnership deal

22 Feb 2021

The manufacturing agreement includes process development for scale-up and technology transfer with the goal of supplying Phase II and III clinical studies

Read more 
Novavax agrees huge supply deal with Gavi for 1.1 billion doses of COVID-19 vaccine

Novavax agrees huge supply deal with Gavi for 1.1 billion doses of COVID-19 vaccine

19 Feb 2021

Biotech will manufacture shots with partner SII for equitable vaccine distribution programme, COVAX

Read more